全球血管阻塞設備市場 - 2008年：美國、歐洲、其他

全球血管阻塞設備市場 - 2008年：美國、歐洲、其他 是由出版商Life Science Intelligence, Inc.在2008年07月所出版的。 這份英文市場調查報告書包含185 Pages / 85 Exhibits 價格從美金5995起跳。

目錄

Abstract

Overview

As analyzed in this report by Life Science Intelligence, the global market for vascular closure devices will reach nearly $1 billion by 2013. The market for vascular closure technologies, which includes implantable devices and external compression products,has traditionally been concentrated in the U.S. and Western Europe. These technologies are used to replace or augment manual compression following diagnostic catheterizations. By reducing time to hemostasis and facilitating more rapid recovery, implantable technologies are able to reduce time in the recovery room, which contributes to better patient throughput and higher profits for catheterization labs. External compression products, which include chemically-treated patches, also simplify the process of vascular closure for the clinician and staff.

LSI expects that by 2013, implantable devices and external compression products will account for nearly half of all vascular closures in the U.S. While implantable devices will account for 56% of all device-based procedures. In Europe, the use of vascular closure devices in the West has been offset by broad use of manual compression in the East. Driven by favorable demographics and better access to technologies, however, vascular closure devices, especially external compression products, should experience greater adoption.

To date, the high cost of implantable vascular closure devices has limited adoption in other international markets. By 2013, however, growing catheterization volumes, better access to new healthcare technologies, an expanding middle class, and the need to increase patient throughput while meeting the standards of Western healthcare will contribute to greater adoption of these technologies. Although only limited use of implantable devices is expected, external compression products, which are significantly less expensive than implantable devices, will experience broader adoption.

Table of Contents

1. EXECUTIVE SUMMARY

• 1.1 Methodology
  • 1.1.1 Supporting Research
• 1.2 Percutaneous Procedure Forecasts
• 1.3 External Compression Products
• 1.4 Implantable Vascular Closure Devices
• 1.5 The Global Market for Vascular Closure

• Exhibit 1-1: Global Catheterizations Requiring Vascular Closure, 2006-2013
• Exhibit 1-2: Selected Vascular Closure Products and Companies, 2008
• Exhibit 1-3: Global Vascular Closure Procedures by Type, 2006-2013
• Exhibit 1-4: Global Vascular Closure Procedures by Type in 2007 & 2013
• Exhibit 1-5: External Compression Products, U.S. Supplier Shares, 2007
• Exhibit 1-6: Implantable Closure Devices, Global Supplier Shares, 2007
• Exhibit 1-7: Vascular Closure Devices, Global Market Forecast, 2006-2013

2. OVERVIEW - OPPORTUNITIES IN VASCULAR CLOSURE

• 2.1 Overview of Global Regions
  • 2.1.1 North America
    • 2.1.1.1 The United States
      • 2.1.1.1.1 The U.S. Healthcare System
    • 2.1.1.2 Canada
  • 2.1.2 Europe
    • 2.1.2.1 Healthcare Systems in Europe
      • 2.1.2.1.1 Western Europe
      • 2.1.2.1.2 Eastern Europe
    • 2.1.2.2 Cardiovascular Disease in Europe
  • 2.1.3 The Rest of the World
    • 2.1.3.1 Relevant Factors in ROW Markets

• Exhibit 2-1: Trends in Global Populations by Region, 2006-2013
• Exhibit 2-2: Prevalence of Cardiovascular Disease in the U.S., 2006-2013
• Exhibit 2-3: Prevalence of Peripheral Vascular Disease in the U.S., 2006-2013
• Exhibit 2-4: Prevalence of Cardiovascular Disease in Europe, 2006-2013
• Exhibit 2-5: Prevalence of Peripheral Vascular Disease in Europe, 2006-2013
• Exhibit 2-6: Prevalence of Cardiovascular Disease in the Rest of the World, 2006-2013
• Exhibit 2-7: Prevalence of Peripheral Vascular Disease in the Rest of the World, 2006-2013

3. VASCULAR ANATOMY, PHYSIOLOGY, AND DISEASE STATES

• 3.1 The Circulatory System
• 3.2 Vascular Anatomy and Physiology
  • 3.2.1 Peripheral Arteries
  • 3.2.2 Coronary Arteries
  • 3.2.3 Arteries of the Head and Neck
• 3.3 Vessel Tissue Structures
• 3.4 The Wound Healing Process
  • 3.4.1 Inflammatory Phase
  • 3.4.2 Proliferative Phase
  • 3.4.3 Remodeling Phase
• 3.5 Other Factors Influencing Vascular Closure
• 3.6 Arterial Access
• 3.7 Vascular Disease States
  • 3.7.1 Arterial Stenosis and Arteriosclerosis
  • 3.7.2 Coronary Stenosis
  • 3.7.3 Peripheral Vascular Disease
    • 3.7.3.1 Carotid Artery Stenosis
    • 3.7.3.2 Subclavian Artery Stenosis
    • 3.7.3.3 Renal Artery Stenosis
    • 3.7.3.4 Iliac Artery Stenosis
  • 3.7.4 Aneurysms
    • 3.7.4.1 Abdominal Aortic Aneurysms
    • 3.7.4.2 Cerebral Aneurysms
  • 3.7.5 Patent Foramen Ovale
  • 3.7.6 Thrombi and Emboli
  • 3.7.7 Venous Thromboembolism
  • 3.7.8 Phlebitis

• Exhibit 3-1: Overview of the Circulatory System
• Exhibit 3-2: Major Vessels of the Cardiovascular System
• Exhibit 3-3: Anatomy and Function of the Blood Vessels
• Exhibit 3-4: Peripheral Arteries and Arteries of the Lower Extremity
• Exhibit 3-5: Coronary Arteries
• Exhibit 3-6: Arteries of the Head and Neck
• Exhibit 3-7: Anatomy of the Arteries and Veins
• Exhibit 3-8: The Wound Healing Process

4. DIAGNOSTIC AND INTERVENTIONAL VASCULAR PROCEDURES

• 4.1 Diagnostic Angiography
  • 4.1.1 Cardiac Angiography
    • 4.1.1.1 Diagnostic Cardiac Catheterizations in the U.S.
    • 4.1.1.2 Diagnostic Cardiac Catheterizations in Europe
    • 4.1.1.3 Diagnostic Cardiac Catheterizations in the Rest of the World
  • 4.1.2 Peripheral Angiography
    • 4.1.2.1 Peripheral Vascular Diagnoses and Therapies in the U.S.
    • 4.1.2.2 Peripheral Vascular Procedures in Europe
    • 4.1.2.3 Peripheral Vascular Procedures in the Rest of the World
  • 4.1.3 Cerebral Angiography
    • 4.1.3.1 Cerebral Angiography Procedures
• 4.2 Interventional Procedures
  • 4.2.1 Percutaneous Interventions
    • 4.2.1.1 PTCA and Stenting
      • 4.2.1.1.1 Percutaneous Coronary Interventions in the U.S.
      • 4.2.1.1.2 Percutaneous Coronary Interventions in Europe
      • 4.2.1.1.3 Percutaneous Coronary Interventions in the Rest of the World
    • 4.2.1.2 Coronary Atherectomy
    • 4.2.1.3 Percutaneous Electrophysiologic Ablation
    • 4.2.1.4 Percutaneous Valve Repair
    • 4.2.1.5 Percutaneous Repair of Patent Foramen Ovale
    • 4.2.1.6 Percutaneous Procedures in the Peripheral Arteries
    • 4.2.1.7 Carotid Angioplasty and Stenting
    • 4.2.1.8 Cerebral Angioplasty and Stenting
    • 4.2.1.9 Peripheral Atherectomy
    • 4.2.1.10 Renal Artery Angioplasty
    • 4.2.1.11 Iliac Artery Angioplasty

• Exhibit 4-1: Diagnostic Cardiac Catheterizations in the U.S., 1996-2013
• Exhibit 4-2: Diagnostic Cardiac Catheterizations in Europe, 1996-2013
• Exhibit 4-3: Diagnostic Cardiac Catheterizations in the Rest of the World, 1996-2013
• Exhibit 4-4: Peripheral Vascular Procedures in the U.S., 1996-2013
• Exhibit 4-5: Peripheral Vascular Procedures in Europe, 1996-2013
• Exhibit 4-6: Peripheral Vascular Procedures in the Rest of the World, 1996-2013
• Exhibit 4-7: Percutaneous Coronary Interventions in the U.S., 1996-2013
• Exhibit 4-8: Percutaneous Coronary Interventions in Europe, 1996-2013
• Exhibit 4-9: Percutaneous Coronary Interventions in Rest of the World, 1996-2013

5. FACTORS DRIVING THE PERFORMANCE OF VASCULAR CLOSURES

• 5.1 Clinical Settings and Needs
  • 5.1.1 Inpatient versus Outpatient Settings
• 5.2 Stages of the Vascular Procedure
  • 5.2.1 Patient Preparation
  • 5.2.2 The Catheterization Procedure
  • 5.2.3 Clean-Up
  • 5.2.4 Vascular Closure
    • 5.2.4.1 Hemostasis
  • 5.2.5 Turnaround
• 5.3 Procedural Economics
  • 5.3.1 Costs
  • 5.3.2 Reimbursement
    • 5.3.2.1 Revenue Codes
    • 5.3.2.2 DRG Codes
    • 5.3.2.3 Reimbursement for Diagnostic Procedures
  • 5.3.3 Economic Justification for Vascular Closure Technologies

• Exhibit 5-1: Global Catheterizations Requiring Arterial Closure, 1996-2013
• Exhibit 5-2: Results of the CLIP Study - Diagnostic Patients
• Exhibit 5-3: Results of the CLIP Study - Interventional Patients
• Exhibit 5-4: Results of Cardiva Medical' s Boomerang Device for Vascular Closure
• Exhibit 5-5: Direct Facility Costs for Diagnostic and Interventional Procedures
• Exhibit 5-6: Average Medicare Reimbursements for Common Catheterization Procedures in 2008

6. VASCULAR CLOSURE DEVICES

• 6.1 Manual Compression
• 6.2 Vascular Closure Devices
  • 6.2.1 Implantable Vascular Closure Devices
    • 6.2.1.1 Implantable Devices and Companies
      • 6.2.1.1.1 Angio-Seal VIP
        • 6.2.1.1.1.1 St. Jude Medical
      • 6.2.1.1.2 Perclose
      • 6.2.1.1.3 StarClose
        • 6.2.1.1.3.1 Abbott Laboratories and Abbott Vascular
      • 6.2.1.1.4 EVS (Expanding Vascular Stapling) Vascular Closure System
        • 6.2.1.1.4.1 Medtronic
      • 6.2.1.1.5 Femoral Introducer Sheath and Hemostasis (FISH) Device
        • 6.2.1.1.5.1 Morris Innovative Research
      • 6.2.1.1.6 SuperStitch
        • 6.2.1.1.6.1 Sutura
      • 6.2.1.1.7 Boomerang
        • 6.2.1.1.7.1 Cardiva Medical
      • 6.2.1.1.8 Mynx Vascular Closure System (VCS)
        • 6.2.1.1.8.1 AccessClosure
  • 6.2.2 External Compression Products
    • 6.2.2.1 External Compression Products & Suppliers
      • 6.2.2.1.1 SyvekPatch
        • 6.2.2.1.1.1 Marine Polymer Technologies
      • 6.2.2.1.2 Chito-Seal
      • 6.2.2.1.3 Clo-Sur P.A.D.
        • 6.2.2.1.3.1 Scion Cardio-Vascular
      • 6.2.2.1.4 D-Stat Dry
        • 6.2.2.1.4.1 Vascular Solutions
      • 6.2.2.1.5 Neptune Pad
        • 6.2.2.1.5.1 TZ Medical
      • 6.2.2.1.6 Safeguard
        • 6.2.2.1.6.1 Datascope
      • 6.2.2.1.7 SafeSeal Patch
        • 6.2.2.1.7.1 Possis Medical
        • 6.2.2.1.7.2 Medafor
    • 6.2.2.1.8 FemoStop
      • 6.2.2.1.8.1 Radi Medical Systems
    • 6.2.2.1.9 CloSys Hemostatic Device
      • 6.2.2.1.9.1 CloSys
    • 6.2.2.1.10 Therus Acoustic Hemostasis System
      • 6.2.2.1.10.1 Therus
      • 6.2.2.1.10.2 Boston Scientific
• 6.3 Effectiveness and Complication Rates Associated with Closure Devices
• 6.4 Global Vascular Closure Market Analysis
  • 6.4.1 Implantable Devices - Supplier Analysis
  • 6.4.2 External Compression Products - Market Analysis

• Exhibit 6-1: Selected Vascular Closure Devices in 2008
• Exhibit 6-2: Time to Hemostasis for Angio-Seal VIP
• Exhibit 6-3: Time to Recovery for Angio-Seal VIP
• Exhibit 6-4: Complication Rates for Angio-Seal VIP
• Exhibit 6-5: The Angio-Seal VIP Procedure
• Exhibit 6-6: The Perclose Procedure
• Exhibit 6-7: Selected Outcomes of Perclose Procedures
• Exhibit 6-8: Complication Rates for Perclose
• Exhibit 6-9: The StarClose Procedure
• Exhibit 6-10: Complication Rates for StarClose
• Exhibit 6-11: Clinical Performance Data for StarClose
• Exhibit 6-12: The EVS Vascular Closure System
• Exhibit 6-13: The EVS Procedure
• Exhibit 6-14: Clinical Results for the EVS System
• Exhibit 6-15: The FISH Procedure
• Exhibit 6-16: Clinical Results of the FISH Device
• Exhibit 6-17: The SuperStitch Procedure
• Exhibit 6-18: The Boomerang Procedure
• Exhibit 6-19: The Mynx Procedure
• Exhibit 6-20: Clinical Results for the Mynx Vascular Closure System
• Exhibit 6-21: Clo-Sur P.A.D., Method of Operation
• Exhibit 6-22: Clinical Results of D-Stat Dry in Diagnostic Procedures
• Exhibit 6-23: Safeguard Pressure Assisted Device
• Exhibit 6-24: CloSys Hemostatic Device
• Exhibit 6-25: Costs of Vascular Complications at Brigham and Women' s Hospital
• Exhibit 6-26: Selected Studies of Major Closure Complications from Diagnostic Catheterization
• Exhibit 6-27: Selected Studies of Minor Closure Complications from Diagnostic Catheterization
• Exhibit 6-28: Selected Studies of Major Closure Complications from Interventional Catheterization
• Exhibit 6-29: Selected Studies of Minor Closure Complications from Interventional Catheterization
• Exhibit 6-30: Complications and Associated Costs of Vascular Closure Procedures
• Exhibit 6-31: Global Catheterizations Requiring Arterial Closure, 1996-2013
• Exhibit 6-32: Global Vascular Closure Procedures by Type in 2007 & 2013
• Exhibit 6-33: U.S. Vascular Closure Procedure Forecast, 2006-2013
• Exhibit 6-34: U.S. Vascular Closure Device Procedures by Type in 2007
• Exhibit 6-35: U.S. Vascular Closure Device Market Forecast, 2006-2013
• Exhibit 6-36: Vascular Closure Procedure Forecast for Europe, 2006-2013
• Exhibit 6-37: Vascular Closure Procedures in Europe by Type in 2007
• Exhibit 6-38: Vascular Closure Device Market Forecast for Europe, 2006-2013
• Exhibit 6-39: Vascular Closure Procedure Forecast for the Rest of the World, 2006-2013
• Exhibit 6-40: Rest of the World Vascular Closure Procedures by Type in 2007
• Exhibit 6-41: Rest of the World Vascular Closure Market Forecast by Type, 2006-2013
• Exhibit 6-42: Global Vascular Closure Procedures by Type, 2006-2013
• Exhibit 6-43: Vascular Closure Devices, Global Market Forecast, 2006-2013
• Exhibit 6-44: U.S. Implantable Closure Devices, Sales by Supplier, 2006-2013
• Exhibit 6-45: U.S. Implantable Closure Devices, Units by Supplier, 2006-2013
• Exhibit 6-46: U.S. Implantable and Semi-Implantable Closure Device Market, Unit Shares by Supplier, 2008
• Exhibit 6-47: Global Implantable and Semi-Implantable Closure Device Market Forecast, Unit Shares by Supplier, 2006-2013
• Exhibit 6-48: U.S. External Compression Products, Supplier Unit Shares, 2007

相關商品

心血管設備相關市場調查報告書

全球心臟輔助裝置的市場(到2017年為止):心室輔助裝置和全人工心臟的普及伴隨的市場成長
Cardiac Assist Devices Market to 2017 - Increasing Uptake of Ventricular Assist Devices and Total Artificial Heart to Drive Growth
價格 : US $ 3500
出版日期 : 2012年01月

經導管心臟瓣膜市場(∼2017年):結構·技術性改善及有益的費用償還方案以推動治療數量的增加
Transcatheter Heart Valve Market to 2017 - Improvements in Design and Technique and a Favorable Reimbursement Scenario to Contribute to Higher Procedure Volumes
價格 : US $ 3500
出版日期 : 2012年01月

南非的心血管設備市場的機會及到2016年為止的成長趨勢預測
South Africa Cardiovascular Devices Market Outlook and Opportunities
價格 : US $ 2500
出版日期 : 2011年12月

Life Science Intelligence, Inc.發行的醫療設備相關市場調查報告書

德國外科處置件數資料庫

Germany Procedure Volumes Database

價格 : US $ 8000

出版日期 : 2011年08月

新興醫療技術企業：2011年第1季

Report on Emerging Medtech Companies in Q1 2011

價格 : US $ 595

出版日期 : 2011年05月

全球的體外照射療法市場：2010年

2011 GLOBAL MARKETS FOR EXTERNAL RADIATION THERAPY

價格 : US $ 6500

出版日期 : 2011年05月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!